ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
82,539.90
0.24%
S&P 500
5,611.85
0.55%
Dow Jones
42,001.76
1.00%
US Dollar vs Yen
149.968
0.26%
Brent Oil
74.675
2.60%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Universe Pharmaceuticals Inc (UPC)

  7. Universe Pharmaceuticals Inc (UPC) ニュース

UPC

Universe Pharmaceuticals (UPC)

Universe Pharmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:UPC
日付受信時刻ニュースソース見出しコード企業名
2025/03/2021 : 33Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
2025/03/2021 : 30GlobeNewswire Inc.Universe Pharmaceuticals INC Announces Share ConsolidationNASDAQ:UPCUniverse Pharmaceuticals Inc
2025/03/1205 : 10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
2025/03/0406 : 10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
2025/02/2606 : 11Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
2025/02/2606 : 10GlobeNewswire Inc.Universe Pharmaceuticals INC Receives Staff Determination Notice from Nasdaq Related to Delayed Annual ReportNASDAQ:UPCUniverse Pharmaceuticals Inc
2025/02/2106 : 05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
2025/02/1906 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
2025/02/1206 : 10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
2025/02/0406 : 10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
2025/02/0406 : 10GlobeNewswire Inc.Universe Pharmaceuticals INC Receives Nasdaq Delisting Notice Subject to Hearing RequestNASDAQ:UPCUniverse Pharmaceuticals Inc
2025/01/3022 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
2025/01/2722 : 30Edgar (US Regulatory)Form NT 20-F - Notification of inability to timely file Form 20-FNASDAQ:UPCUniverse Pharmaceuticals Inc
2024/12/1306 : 31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
2024/12/1107 : 00GlobeNewswire Inc.Univest Securities, LLC Announces Closing of $15 Million Registered Direct Offering for its Client Universe Pharmaceuticals INC (NASDAQ: UPC)NASDAQ:UPCUniverse Pharmaceuticals Inc
2024/12/1006 : 15Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:UPCUniverse Pharmaceuticals Inc
2024/12/0921 : 00GlobeNewswire Inc.Universe Pharmaceuticals INC Announces $15 Million Registered Direct OfferingNASDAQ:UPCUniverse Pharmaceuticals Inc
2024/11/1322 : 02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
2024/11/1322 : 00GlobeNewswire Inc.Universe Pharmaceuticals INC Announces Share ConsolidationNASDAQ:UPCUniverse Pharmaceuticals Inc
2024/11/0205 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
2024/11/0205 : 00GlobeNewswire Inc.Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price DeficiencyNASDAQ:UPCUniverse Pharmaceuticals Inc
2024/10/1105 : 10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
2024/09/2805 : 05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
2024/09/2105 : 15GlobeNewswire Inc.Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2024NASDAQ:UPCUniverse Pharmaceuticals Inc
2024/09/2105 : 15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
2024/09/0405 : 10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
2024/07/1905 : 05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
2024/06/1013 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:UPCUniverse Pharmaceuticals Inc
2024/05/1505 : 06Edgar (US Regulatory)Form F-1/A - Registration statement for certain foreign private issuers: [Amend]NASDAQ:UPCUniverse Pharmaceuticals Inc
2024/02/0722 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:UPCUniverse Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:UPC

最近閲覧した銘柄

LSE
41CO
Kommunal Nts
ASX
NGIN
Deferred Settlement Trad...
LSE
15TA
Ab Sveriges 26
TG
JEGA
JPM Global Equity Premiu...
TSX
ARKK
BMO ARK Innovation Fiund
TSX
HREU
BetaPro Equal Weight Can...
BIBX
QNTUSDT
Quant
TSX
TRVI
Harvest Travel and Leisu...
TSXV
NIKL
GK Resources
EU
SNBR
SNCF Reseau 1% 09nov2031
AMEX
REPX
Riley Exploration Permian
LSE
EVOL
TSX
ESGA
BMO MSCI Canada Selectio...
TSX
SPLT
Brompton Split Corp Pref...
TSX
FGEB
Fidelity Global Equity P...
ASX
MGUO
Magnum Mining and Explor...
Delayed Upgrade Clock
ADVFN Logo
日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2025 ADVFN PLC - 全著作権所有

広告を削除する

サインアップして広告なしのエクスペリエンスを体験してください

広告なし

今すぐ試してください

広告を残す